MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0020264
Nine Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.08 Cr
▼ 34% YoY
Net profit · FY 2025
₹7.25 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹1.05 Cr
EBITDA margin 50.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Nine Labs Private Limited
Data last updated:
Nine Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC057818. Its GSTIN is 36AADCN7670B1ZJ (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Munnamgi Radhika Reddy and Munnamgi Anoushka Reddy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy No 71 & 72 H No 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla, Hyderabad, Telangana, India – 500067.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.08 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹7.25 Lakh (net margin 3.5%) and EBITDA of ₹1.05 Cr (EBITDA margin 50.8%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 30% over five years.
Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending.
Nine Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0020264). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ninelabs.co.in.
Company Details of Nine Labs Private Limited
CIN U24232TG2008PTC057818
Registration Number 057818
Incorporation Date 26 February 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0020264
CIN History of Nine Labs Private Limited
Nine Labs has one previous CIN (Corporate Identification Number): U24232AP2008PTC057818. The current CIN is U24232TG2008PTC057818, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008PTC057818 | Current |
| U24232AP2008PTC057818 | Previous |
Recognitions & Rankings of Nine Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressSy No 71 & 72 H No 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla, Hyderabad, Telangana, India – 500067
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Nine Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Nine Labs Private Limited
The main business activity of Nine Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nine Labs Private Limited FY 2025 filings available
Nine Labs Private Limited reported revenue of ₹2.08 Cr (down 34% YoY) for FY 2025.
Revenue · FY 2025
₹2.08 Cr ▼ 34%
Net profit · FY 2025
₹7.25 Lakh margin 3.5%
EBITDA · FY 2025
₹1.05 Cr margin 50.8%
Compounded Annual Growth Rate (CAGR) of Nine Labs Private Limited
Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 33%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▲ 293%
3 years · compounded
▲ 16%
5 years · compounded
▲ 7%
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 34% fall in the latest year. EBITDA rose 293% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nine Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.05 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.25 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nine Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 50.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nine Labs are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nine Labs Private Limited
Nine Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munnamgi Radhika Reddy Also directs: Apithecary Pharma Private Limited | Director | 26 Feb 2008 | 18 Years 7 Months | Current |
| Munnamgi Anoushka Reddy Also directs: Apithecary Pharma Private Limited | Director | 05 Jul 2019 | 7 Years 3 Months | Current |
Peer Comparison of Nine Labs Private Limited
Nine Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Relic Biotechnology Private Limited | ₹2.09 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Pune, Maharashtra, India |
| Phenix Pharma Private Limited | ₹2.09 Cr (FY 2022) | •••• | •••• | -31.0% | •••• | Vadodara, Gujarat, India |
| Seven Hiills Softgel Private Limited | ₹2.08 Cr (FY 2021) | •••• | •••• | 20.0% | •••• | Hyderabad, Telangana, India |
| Wellogen Pharma Private Limited | ₹2.08 Cr (FY 2023) | •••• | •••• | 35.0% | •••• | Ahmedabad, Gujarat, India |
| Zebx Pharmaceuticals Private Limited | ₹2.08 Cr (FY 2025) | •••• | •••• | 492.0% | •••• | Aramane Nagar, Karnataka, India |
| Nine Labs Private Limited this company | ₹2.08 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Hyderabad, Telangana, India |
| Matrubhumi Chemical Private Limited | ₹2.08 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Malegaon, Maharashtra, India |
| Macromed Pharmaceuticals Private Limited | ₹2.07 Cr (FY 2020) | •••• | •••• | -1.0% | •••• | Puducherry, India |
| Iressia Life Sciences Private Limited | ₹2.07 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Vapi, Gujarat, India |
| Morphil Health Care Private Limited | ₹2.07 Cr (FY 2025) | •••• | •••• | 63.0% | •••• | Patna, Bihar, India |
| Forel Labs Private Limited | ₹2.05 Cr (FY 2024) | •••• | •••• | -87.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Nine Labs by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nine Labs Private Limited
Nine Labs Private Limited is audited by M V NARAYANA REDDY AND CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M V NARAYANA REDDY AND CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nine Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nine Labs Private Limited
Nine Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Nine Labs Private Limited
Nine Labs Private Limited has 3 court cases on record: 3 filed by Nine Labs. 2 cases are pending and 1 is disposed.
Total cases
3
Filed by the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed by the company against individuals | Pending |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed by the company against Vaasavaa Pharmaceuticals PRV. Ltd., Rep.By.It S Manging Director and 4 Anothers | Disposed |
Premium access
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Nine Labs Private Limited
Employment history and EPFO contributions of people linked to Nine Labs.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nine Labs Private Limited
Nine Labs Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Narender Reddy Nalla ceased to be Director on 19 Dec 2019.
AGM
Nine Labs Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Nine Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Narender Reddy Nalla ceased to be Director.
Ceased
Munnamgi Anoushka Reddy ceased to be Additional Director.
Appointed
Munnamgi Anoushka Reddy was appointed as Director.
Ceased
Narasimha Reddy Enukonda ceased to be Director.
Ceased
Kiran Kumar Nalamothu ceased to be Director.
Appointed
Munnamgi Radhika Reddy was appointed as Director.
Incorporation
26 Feb 2008
Nine Labs Private Limited was registered on 26 Feb 2008 with Roc Hyderabad & aged 18 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Nine Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nine Labs Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nine Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nine Labs Private Limited
Nine Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCN7670B1ZJ | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nine Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nine Labs Private Limited
Nine Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 February 2008 (18+ years old) and is registered under CIN U24232TG2008PTC057818.
Nine Labs reported revenue of ₹2.08 Cr for FY 2025 (down 34% YoY).
Nine Labs has 2 current directors:
- Munnamgi Radhika Reddy - Director
- Munnamgi Anoushka Reddy - Director
Nine Labs reported a net profit of ₹7.25 Lakh (net margin 3.5%) and EBITDA of ₹1.05 Cr (EBITDA margin 50.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nine Labs is -33% over three years and -30% over five years. In the latest year (FY 2025) revenue fell 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nine Labs is 36AADCN7670B1ZJ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nine Labs is U24232TG2008PTC057818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nine Labs has 3 court cases on record: 3 filed by the company. 2 are pending.
Nine Labs was incorporated on 26 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nine Labs by revenue are Relic Biotechnology Private Limited, Phenix Pharma Private Limited, Seven Hiills Softgel Private Limited, Wellogen Pharma Private Limited, Zebx Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Narender Reddy Nalla ceased to be Director on 19 Dec 2019. Munnamgi Anoushka Reddy ceased to be Additional Director on 29 Jul 2019. Munnamgi Anoushka Reddy was appointed as Director on 05 Jul 2019. Nine Labs has 6 board changes on record in total.